Kevin Flinn

Kevin Flinn has extensive experience in regulatory affairs within the pharmaceutical industry, beginning with a Bachelor of Science in Cellular/Molecular Biology from Troy University. Flinn held various positions, starting as a Regulatory Affairs Product Specialist at Mallinckrodt Pharmaceuticals, where responsibilities included managing eCTD submissions and regulatory filings. This role progressed to Senior Regulatory Affairs Product Specialist before Flinn moved to Huvepharma, Inc. as a Regulatory Affairs Specialist, focusing on FDA report submissions. Most recently, Flinn served as Manager Regulatory Affairs CMC at Boehringer Ingelheim and subsequently as Manager of Global Regulatory Affairs CMC Pharmaceuticals at Azurity Pharmaceuticals. This experience encompasses a broad range of regulatory activities, ensuring compliance and facilitating the lifecycle management of pharmaceutical products.